The ROMK-cystic fibrosis transmembrane conductance regulator connection: New insights into the relationship between ROMK and cystic fibrosis transmembrane conductance regulator channels

Current Opinion in Nephrology and Hypertension

Volumn 7, Issue 1, 1998, Pages 49-58

  Ho, Kevin ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM); POTASSIUM CHANNEL; TRANSMEMBRANE CONDUCTANCE REGULATOR;

CHANNEL GATING; CYSTIC FIBROSIS; HUMAN; PATHOPHYSIOLOGY; POTASSIUM CONDUCTANCE; PRIORITY JOURNAL; PROTEIN DETERMINATION; REVIEW; SEQUENCE HOMOLOGY; SLOW INWARD CURRENT; STRUCTURE ANALYSIS;

ADENOSINE TRIPHOSPHATE; ANIMALS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; HUMANS; ION CHANNELS; KIDNEY; POTASSIUM CHANNELS; POTASSIUM CHANNELS, INWARDLY RECTIFYING;

EID: 0031964924     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-199801000-00009     Document Type: Review

References (120)

1. Ho K, Nichols CG, Lederer WJ, Lytton J, Vassilev PM, Kanazirska MV, et al. Cloning and expression of an inwardly rectifying ATP-regulated potassium channel. Nature 1993; 362:31-38.
2. Kubo Y, Baldwin TJ, Jan YN, Jan LY. Primary structure and functional expression of a mouse inward rectifier potassium channel. Nature 1993; 362:127-133.
3. Kubo Y, Reuveny E, Slesinger PA, Jan YN, Jan LY. Primary structure and functional expression of a rat G-protein-coupled muscarinic potassium channel. Nature 1993; 364:802-806.
4. Lang F, Rehwald W. Potassium channels in renal epithelial transport regulation. Physiol Rev 1992; 72:1-32.
5. Wang W, Sackin H, Giebisch G. Renal potassium channels and their regulation. Annu Rev Physiol 1992; 54:81-96.
6. Doupnik CA, Davidson N, Lester HA. The inward rectifier potassium channel family. Curr Opin Neurobiol 1995; 5:268-277.
7. Nichols CG, Lopatin AN. Inward rectifier potassium channels. Annu Rev Physiol 1997; 59:171-191.
8. + channel in thick ascending limb of rat kidney. Am J Physiol 1994; 267:F599-F605.
9. Wang W, White S, Geibel J, Giebisch G. A potassium channel in the apical membrane of rabbit thick ascending limb of Henle's loop. Am J Physiol 1990; 258:F244-F253.
10. Frindt G, Palmer LG. Low-conductance K channels in apical membrane of rat cortical collecting tubule. Am J Physiol 1989; 256:F143-F151.
11. + channel in apical membrane of rat cortical collecting tubule. Am J Physiol 1990; 259:F494-F502.
12. + channel of the thick ascending limb of Henle's loop. Pflügers Arch 1990; 415:449-460.
13. + secretion through the apical K channel of cortical collecting duct. Kidney Int 1995; 48:1024-1030.
14. + channels in rat CCD. Am J Physiol 1993; 264:F502-F509.
15. + channel of cortical collecting duct of rat kidney. Am J Physiol 1992; 262:F554-F559.
16. + channel of the rat cortical collecting duct. J Gen Physiol 1991; 98:35-61.
17. + channel by protein kinases A and C. Proc Natl Acad Sci USA 1991; 88:9722-9725.
18. + channel inhibition in rat CCD principal cell. Am J Physiol 1995; 268:F211-219.
19. Ashcroft SJH, Ashcroft FM. Properties and functions of ATP-sensitive K-channels. Cell Signal 1990; 2:197-214.
20. Ashcroft FM. Adenosine 5′-triphosphate-sensitive potassium channels. Annu Rev Neurosci 1988; 11:97-118.
21. + channel by membrane-bound protein phosphatases in rat principal tubule cell. Am J Physiol 1995; 269:F355-F362.
22. Wang T, Wang W, Klein-Robbenhaar G, Giebisch G. Effects of glyburide on renal tubule transport and potassium-channel activity. Renal Physiol Biochem 1995; 18:169-182.
23. + channels in cardiac muscle. Nature 1983; 305:147-148.
24. + channel-opening drugs. Am J Physiol 1995; 269:C525-C545.
25. Aguilar-Bryan L, Nichols CG, Wechsler SW, Clement JP IV, Boyd AE III. González G, et al. Cloning of the β cell high-affinity sulfonylurea receptor: a regulator of insulin secretion. Science 1995; 268:423-426.
26. Bond CT, Pessia M, Xia X-M, Lagrutta A, Kavanaugh MP, Adelman JP. Cloning and expression of a family of inward rectifier potassium channels. Recept Chan 1994; 2:183-191.
27. KATP: an inward rectifier subunit plus the sulfonylurea receptor. Science 1995; 270:1166-1170.
28. Inagaki N, Tsuura Y, Namba N, Masuda K, Gonoi T, Horie M, et al. Cloning and functional characterization of a novel ATP-sensitive potassium channel ubiquitously expressed in rat tissues, including pancreatic islets, pituitary, skeletal muscle, and heart. J Biol Chem 1995; 270:5691-5694.
29. Sakura H, Ämmälä C, Smith PA, Gribble FM, Ashcroft FM. Cloning and functional expression of the cDNA encoding a novel ATP-sensitive potassium channel subunit expressed in pancreatic β-cells, brain, heart and skeletal muscle. FEBS Lett 1995; 377:338-344.
30. + channels. Neuron 1996; 16:1011-1017.
31. ATP channels.
32. ATP channels. Diabetes 1996; 45:1439-1445.
33. Hyde SC, Emsley P, Hartshorn MJ, Mimmack MM, Gileadi U, Pearce SR, et al. Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport. Nature 1990; 346:362-365.
34. Higgins CF. ABC transporters: from microorganisms to man. Annu Rev Cell Biol 1992; 8:67-113.
35. Higgins CF. The ABC of channel regulation. Cell 1995; 82:693-696.
36. Tusnády GE, Bakos É, Váradi A, Sarkadi B. Membrane topology distinguishes a subfamily of the ATP-binding cassette (ABC) transporters. FEBS Lett 1997; 402:1-3.
37. ••].
38. ATP channel pore is formed by a tetramer of Kir 6.2 subunits and that a solitary SUR1 protein is associated with each Kir subunit to form a functional channel.
39. + currents.
40. Nichols CG, Shyng S-L, Nestorowicz A, Glaser B, Clement JP IV, Gonzalez G, et al. Adenosine diphosphate as an intracellular regulator of insulin secretion. Science 1996; 272:1785-1787.
41. Thomas PM, Cote GJ, Wohllk N, Haddad B, Mathew PM, Rabl W, et al. Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science 1995; 268:426-429.
42. Dunne MJ, Kane C, Shepherd RM, Sanchez JA, James RFL, Johnson PRV, et al. Familial persistent hyperinsulinemic hypoglycemia of infancy and mutations in the sulfonylurea receptor. N Engl J Med 1997; 336:703-706.
43. ATP channel activity in COSm6 cells.
44. ATP channel function by targeting the inward rectifier Kir 6.2 channel. The mutation results in a proline substitution at residue 147 in the second transmembrane segment, M2.
45. ATP channels.
46. + channel Kir 6.1 expressed in human embryonic kidney cells. J Physiol 1996; 494:709-714.
47. + channel. J Physiol 1997; 499:715-720.
48. Gribble FM, Tucker SJ, Ashcroft FM. The essential role of the Walker A motifs of SUR1 in K-ATP channel activation by Mg-ADP and diazoxide. EMBO J 1997; 16:1145-1152. Walker A motif mutations of NBD1 and NBD2 in SUR1 do not significantly affect ATP sensitivity or channel reactivation by MgATP, but do affect MgADP potentiatory effects (activation and antagonism of ATP inhibition), suggesting the role for both NBDs in these effects. An intact NBD1 is also required for channel activation by diazoxide. Also [40].
49. + channels in the absence of the sulphonylurea receptor. Nature 1997; 387:179-183. Although Kir 6.2 expression does not elicit channel activity in the absence of SUR1, Kir 6.2 subunits which are truncated at the C-terminus can form functional channels when expressed alone. SUR1 does not contribute significantly to the ion permeation pathway. Significantly, these mutants exhibit intrinsic ATP sensitivity that is enhanced by coexpression with SUR1, suggesting a Kir 6.2 ATP-inhibitory site; mutation of Lys 185 results in a reduction in ATP sensitivity. SUR1 confers tolbutamide and diazoxide sensitivity on these mutant Kir 6.2 channels.
50. + channel, ROMK. Nature Genet 1996; 14:152-156. This paper provides the first demonstration that mutations in Kir 1.1 channels produce a variant of Bartter's syndrome, therefore establishing the genetic heterogeneity of the syndrome (mutations of Na-K-2Cl cotransporter and Kir 1.1 genes, SLC12A1 and KCNJ1) and confirming the physiologic role of these renal Kir channels.
51. International Collaborative Study Group for Bartter-like Syndromes. Mutations in the gene encoding the inwardly-rectifying renal potassium channel, ROMK, cause the antenatal variant of Bartter syndrome: evidence for genetic heterogeneity. Hum Mol Genet 1997; 6:17-26. This paper reports additional mutations of the Kir 1.1 channel subunit responsible for Bartter's syndrome involving MO, both transmembrane segments (M1, M2), the M1-H5 linker, the putative nucleotide-binding site, and the distal C-terminus.
52. Kenna S, Röper J, Ho K, Hebert S, Ashcroft SJH, Ashcroft FM. Differential expression of the inwardly-rectifying K-channel ROMK1 in rat brain. Mol Brain Res 1994; 24:353-356.
53. + channel, ROMK6 (Kir 1.1f). FEBS Lett 1996; 399:122-126.
54. Zhou H, Tate SS, Palmer LG. Primary structure and functional properties of an epithelial K channel. Am J Physiol 1994; 266:C809-C824.
55. + channel II. Cloning and distribution of alternative forms. Am J Physiol 1995; 268:F1132-F1140.
56. + channel ROMK1 mRNA. Mol Pharmacol 1994; 45:854-860.
57. Shuck ME, Bock JH, Benjamin CW, Tsai T-D, Lee KS, Slightom JL, et al. Cloning and characterization of multiple forms of the human kidney ROMK potassium channel. J Biol Chem 1994; 269:24261-24270.
58. + channel I. Expression in rat distal nephron segments. Am J Physiol 1995; 268:F1124-F1131.
59. + channel. Am J Physiol 1995; 268:C389-C401.
60. + channel, ROMK1. Am J Physiol 1996; 271:F588-F594.
61. Löffler K, Hunter M. Cation permeation and blockade of ROMK1, a cloned renal potassium channel. Pflügers Arch 1997; 434:151-158.
62. + channel. Nature 1994; 371:243-246.
63. + channels localized to a single negatively charged residue. Nature 1994; 371:246-249.
64. Lopatin AN, Makhina EN, Nichols CG. Potassium channel block by cyloplasmic polyamines as the mechanism of intrinsic rectification. Nature 1994; 372:366-369.
65. + channels. Science 1994; 266:1068-1072.
66. + channel. Neuron 1995; 14:1047-1054.
67. + channel expressed in Xenopus oocytes. Am J Physiol 1995; 268:C1173-C1178.
68. a; mutation of this residue (K80M) results in a loss of pH sensitivity. Introduction of a lysine residue at the corresponding position in the pH-insensitive Kir 2.1 channel confers sensitivity to intracellular pH.
69. + channel activity involves phosphorylation processes. Proc Natl Acad Sci USA 1994; 91:8077-8081.
70. + channel, ROMK, by cyclic AMP-dependent protein kinase. J Biol Chem 1996; 271:9313-9319.
71. Knighton DR, Cadena DL, Zheng J, Ten Eyck LF, Taylor SS, Sowadski JM, et al. Structural features that specify tyrosine kinase activity deduced from homology modeling of the epidermal growth factor receptor. Proc Natl Acad Sci USA 1993; 90:5001-5005.
72. Zheng J, Knighton DR, Ten Eyck LF, Karlsson R, Xuong N-H, Taylor SS, et al. Crystal structure of the catalytic subunit of cAMP-dependent protein kinase complexed with MgATP and peptide inhibitor. Biochem 1993; 32:2154-2161.
73. + channel. Nature 1994; 371:243-246.
74. Ruknudin A, Schulze DH, Sullivan SK, Lederer WJ, Welling PA. Novel subunit composition in a renal epithelial KATP channel (Kir 1.1 + CFTH) [Abstract]. Biophys J 1997; 72:A33.
75. Takumi T, Ishii T, Horio Y, Morishige K-I, Takahashi N, Yamada M, et al. A novel ATP-dependent inward rectifier potassium channel expressed predominantly in glial cells. J Biol Chem 1995, 270:16339-16346.
76. + channel (ROMK2). Am J Physiol 1996; 271:F275-F285. This paper provides evidence suggesting that Kir 1.1 channels have an intrinsic ATP sensitivity mediated by the putative nucleotide-binding site when expressed in the absence of SUH1 or CFTH [K, (Kir 1.1b) = 2.3mmol/I MgATP]; a Walker A mutation, H206G, augments the ATP sensitivity of Kir 1.1b. A second NBD mutation, G204D, is associated with rapid channel run-down in the presence of MgATP and PKA.
77. ATP channel.
78. Nichols CG, Lederer WJ. Adenosine triphosphate-sensitive potassium channels in the cardiovascular system. Am J Physiol 1991; 261:H1675-H1686.
79. Ämmälä C, Moorhouse A, Gribble F, Ashfield R, Proks P, Smith PA, et al. Promiscuous coupling between the sulfonylurea receptor and inwardly rectifying potassium channels. Nature 1996; 379:545-548.
80. + currents. Am J Physiol 1996; 271:C1565-C1573.
81. McNicholas CM, Nason MW Jr, Guggino WB, Schwiebert EM, Hebert SC, Giebisch G, et al. A functional CFTR-NBF1 is required for ROMK2-CFTR interaction. Am J Physiol 1997; 273:F843-F848.
82. Riordan JR, Rommens JM, Kerem B-S, Alon N, Rozmahel R, Grzelczak Z, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989; 245:1066-1073.
83. Welsh MJ, Anderson MP, Rich DP, Berger HA, Denning GM, Ostedgaard LS, et al. Cystic fibrosis transmembrane conductance regulator: a chloride channel with novel regulation. Neuron 1992; 8:821-829.
84. Anderson MP, Gregory RJ, Thompson S, Souza DW, Paul S, Mulligan RC, et al. Demonstration that CFTR is a chloride channel by alteration of its anion selectivity. Science 1991; 253:202-205.
85. Sheppard DN, Rich DP, Ostedgaard LS, Gregory RJ, Smith AE, Welsh MJ. Mutations in CFTR associated with mild-disease form Cl channels with altered pore properties. Nature 1993; 362:160-164.
86. Tabcharani JA, Rommens JM, Hou Y-X, Chang X-B, Tsui L-C, Riordan JR, et al. Multi-ion pore behavior in the CFTR chloride channel. Nature 1993, 366:79-82.
87. Bear CE, Li C, Kartner N, Bridges RJ, Jensen TJ, Ramjeesingh M, et al. Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR). Cell 1992; 66:809-818.
88. Baukrowitz T, Hwang T-C, Nairn AC, Gadsby DC: Coupling of CFTR Cl channel gating to an ATP hydrolysis cycle. Neuron 1994; 12:473-482.
89. Gunderson KL, Kopito RR. Conformational states of CFTR associated with channel gating: the role of ATP binding and hydrolysis. Cell 1995; 82:231-239.
90. Carson MR, Travis SM, Welsh MJ. The two nucleotide-binding domains of cystic fibrosis transmembrane conductance regulator (CFTR) have distinct functions in controlling channel activity. J Biol Chem 1995; 270:1711-1717.
91. Barasch J, Kiss B, Prince A, Saiman L, Gruenert D, Al-Awqati Q. Defective acidification of intracellular organelles in cystic fibrosis. Nature 1991; 352:70-73.
92. Bradbury NA, Jilling T, Berta G, Sorscher EJ, Bridges RJ, Kirk KL. Regulation of plasma membrane recycling by CFTR. Science 1992; 256:530-532.
93. Greger R, Mall M, Bleich M, Ecke D, Warth R, Riedemann N, et al. Regulation of epithelial ion channels by the cystic fibrosis transmembrane conductance regulator. J Mol Med 1996; 74:527-534.
94. - channels by protein kinase A corrected by insertion of CFTR. Nature 1992; 358:581-584.
95. Gabriel SE, Clarke LL, Boucher RC, Stutts MJ. CFTR and outward rectifying chloride channels are distinct proteins with a regulatory relationship. Nature 1993; 363:263-266.
96. Reddy MM, Quinton PM, Haws C, Wine JJ, Grygorczyk R, Tabcharani JA, et al. Failure of the cystic fibrosis transmembrane conductance regulator to conduct ATP. Science 1996; 271:1876-1879.
97. Li C, Ramjeesingh M, Bear CE. Purified cystic fibrosis transmembrane conductance regulator (CFTR) does not function as an ATP channel. J Biol Chem 1996; 271:11623-11626.
98. Stutts MJ, Canessa CM, Olsen JC, Hamrick M, Cohn JA, Rossier BC, et al. CFTR as a cAMP-dependent regulator of sodium channels. Science 1995; 269:847-850.
99. Crawlord I, Maloney PC, Zeitlin PL, Guggino WB, Hyde SC, Turley H, et al. Immunocytochemical localization of the cystic fibrosis gene product CFTR. Proc Natl Acad Sci USA 1991; 88:9262-9266.
100. Morales MM, Carroll TP, Morita T, Schwiebert EM, Devuyst O, Wilson PD, et al. Both the wild type and a functional isoform of CFTR are expressed in kidney. Am J Physiol 1996; 270:F1038-F1048. CFTR is expressed predominantly in proximal tubule, TAL, and CCD. A functional alternatively spliced form that lacks transmembrane segments TM7-TM12 and NBD2, TNR-CFTR, is the primary form expressed in outer medullary collecting duct, inner medullary collecting duct, and thin limb. TNR-CFTR retains cAMP-activated Cl channel activity (inhibited by glibenclamide) and the ability to regulate outwardly rectifying Cl channels.
101. Todd-Turla KM, Rusvai E, Náray-Fejes-Tóth A, Géza Fejes-Tóth G. CFTR expression in cortical collecting duct cells. Am J Physiol 1996; 270:F237-F244.
102. + channel regulators on cystic fibrosis transmembrane conductance regulator chloride currents. J Gen Physiol 1992; 100:573-591.
103. Schultz BD, DeRoos ADG, Venglarik CJ, Singh AK, Frizzell RA, Bridges RJ. Glibenclamide blockade of CFTR chloride channels. Am J Physiol 1996; 271:L192-L200.
104. - transport via the cystic fibrosis gene product in human epithelial cells. Pflügers Arch 1994; 426:284-287.
105. - channel. Pflügers Arch 1995; 429:659-662.
106. + channel blocker, inhibits cardiac cAMP-activated Cl conductance. Circ Res 1995; 77:417-423.
107. Schwiebert EM, Egan ME, Hwang T-H, Fulmer SB, Allen SS, Cutting GR, et al. CFTR regulates outwardly rectifying chloride channels through an autocrine mechanism involving ATP. Cell 1995; 81:1063-1073.
108. Ashcroft SJH, Ashcroft FM. The sulfonylurea receptor. Biochim Biophys Acta 1992; 1175:45-59.
109. Venglarik CJ, Schultz BD, DeRoos ADG, Singh AK, Bridges RJ. Tolbutamide causes open channel blockade of CFTR Cl channels. Biophys J 1996; 70:2696-2703.
110. Okuno S, Inaba M, Nishizawa Y, Inoue A, Morii H. Effect of glyburide and tolbutamide on cAMP-dependent protein kinase activity in rat liver cytosol. Diabetes 1988; 37:857-861.
111. +-channel blocker glyburide in conscious rats. J Pharmacol Exp Ther 1993; 265:933-937.
112. 2+ and phosphorylation in normal (T84) and cystic fibrosis (CFPAC-1) epithelial cells. Pflügers Arch 1995; 429:355-363.
113. Robson AM, Tateishi S, Ingerfinger JR, Strominger DB, Klahr S. Renal function in patients with cystic fibrosis. J Pediatr 1971; 79:42-50.
114. Assael BM, Marra G, Tirelli AS, Cavanna G, Claris Appiani A, Giunta A, et al. Renal function in cystic fibrosis. Int J Pediatr Nephrol 1986; 7:213-216.
115. Berg U, Kusoffsky E, Strandvik B. Renal function in cystic fibrosis with special reference to the renal sodium handling. Acta Paediatr Scand 1982; 71:833-838.
116. Strandvik B, Berg U, Kallner A, Kusoffsky E. Effect on renal function of essential fatty acid supplementation in cystic fibrosis. J Pediatr 1989; 115:242-250.
117. Kennedy JD, Dinwiddie R, Daman-Willems C, Dillon MJ, Matthew DJ. Pseudo-Bartter's syndrome in cystic fibrosis. Arch Dis Child 1989: 65:786-787.
118. Leoni G, Pitzalis S, Podda R, Zanda M, Silvetti M, Caocci L, et al. A specific cystic fibrosis mutation (T3381) associated with the phenotype of isolated hypotonic dehydration. J Pediatr 1995; 127:281-283.
119. Bates CM, Baum M, Quigley R. Cystic fibrosis presenting with hypokalemia and metabolic alkalosis in a previously healthy adolescent. J Am Soc Nephrol 1997; 8:352-356.
120. Katz SM, Krueger LJ, Falkner B. Microscopic nephrocalcinosis in cystic fibrosis. N Engl J Med 1988; 319:263-266.